Literature DB >> 28495906

Emergency corneal grafting in the UK: a 6-year analysis of the UK Transplant Registry.

Parwez Hossain1,2, Abdo Karim Tourkmani2, Dimitri Kazakos1, Mark Jones3, David Anderson2.   

Abstract

BACKGROUND: Corneal graft (CG) surgery is the most common and successful tissue transplant worldwide. A small and important group of patients are operated in emergency situations, typically to save a perforated eye. Our knowledge of the indications and outcomes of emergency corneal graft (eCG) is limited.
METHODS: Retrospective, multifactorial analysis of all CGs registered by the UK Transplant Service from April 1999 to March 2005.
RESULTS: A total of 12 976 CGs were performed. 1330 (11.4%) were eCGs including 433 regrafts. Actual perforation occurred in 876 (65.9%) patients. 420 (31.5%) grafts were for tectonic purposes alone and 217 (16.3%) were also grafted for visual rehabilitation. The main diagnostic categories were infection (39.4%), non-infectious ulcerative keratitis (32.2%) and other causes (ectasias, previous ocular surgery, injury, dystrophies and opacification). Graft survival of first eCG at 1, 2 and 5 years was 78%, 66% and 47%, respectively. Best-corrected visual acuity of surviving grafts at 1 year was: 6/12 or better in 29.9%, 6/18 to 6/60 in 38.4%, counting finger to LP in 30.6% and NPL in 1%, with worsening of vision in only 8.7% of the patients.
CONCLUSION: This study which is the largest of its kind shows that despite the seriousness of the critical corneal pathology and the surgical challenges that it poses, the outcomes of eCG are favourable with most patients keeping their eyesight and avoiding immediate rejection. These clinical outcomes show the value of eye banking facilities that are developed to support corneal tissue supply for eCG. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Cornea; Immunology; Trauma; infection

Mesh:

Year:  2017        PMID: 28495906     DOI: 10.1136/bjophthalmol-2016-309870

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  9 in total

1.  Corneal cross-linking guards against infectious keratitis: an experimental model.

Authors:  Ayah Marrie; Abdussalam M Abdullatif; Sherief Gamal El Dine; Rania Yehia; Randa Saied; Doaa Ahmed Tolba
Journal:  Int Ophthalmol       Date:  2022-10-18       Impact factor: 2.029

Review 2.  Indications, surgical procedures and outcomes of keratoplasty at a Tertiary University-based hospital: a review of 10 years' experience.

Authors:  Eman M Al-Sharif; Majed Alkharashi
Journal:  Int Ophthalmol       Date:  2021-02-24       Impact factor: 2.031

3.  Microbial keratitis-the true costs of a silent pandemic?

Authors:  Parwez Hossain
Journal:  Eye (Lond)       Date:  2021-02-16       Impact factor: 4.456

4.  Total Penetrating Keratoplasty: Indications, Therapeutic Approach, and Long-Term Follow-Up.

Authors:  Katarzyna Krysik; Ewa Wroblewska-Czajka; Anita Lyssek-Boron; Edward A Wylegala; Dariusz Dobrowolski
Journal:  J Ophthalmol       Date:  2018-04-19       Impact factor: 1.909

5.  Long-term outcomes of riboflavin photodynamic antimicrobial therapy as a treatment for infectious keratitis.

Authors:  Jaime D Martinez; Alejandro Arboleda; Andrea Naranjo; Mariela C Aguilar; Heather Durkee; Pedro Monsalve; Sander R Dubovy; Kendall E Donaldson; Darlene Miller; Guillermo Amescua; Jean-Marie Parel
Journal:  Am J Ophthalmol Case Rep       Date:  2019-06-01

6.  Combined Photoactivated Chromophore for Infectious Keratitis-Corneal Collagen Cross-Linking (PACK-CXL) and Therapeutic Penetrating Keratoplasty for Resistant Bacterial Keratitis.

Authors:  Ashraf Bor'i; Wael M El-Haig
Journal:  Clin Ophthalmol       Date:  2022-02-03

7.  Amniotic membrane transplantation for infectious keratitis: a systematic review and meta-analysis.

Authors:  Darren Shu Jeng Ting; Christin Henein; Dalia G Said; Harminder S Dua
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.996

Review 8.  A 27-Year Report from the Central Eye Bank of Iran.

Authors:  Mohammad Ali Javadi; Mozhgan Rezaei Kanavi; Sare Safi
Journal:  J Ophthalmic Vis Res       Date:  2020-04-06

9.  Evaluation of Host Defense Peptide (CaD23)-Antibiotic Interaction and Mechanism of Action: Insights From Experimental and Molecular Dynamics Simulations Studies.

Authors:  Darren Shu Jeng Ting; Jianguo Li; Chandra S Verma; Eunice T L Goh; Mario Nubile; Leonardo Mastropasqua; Dalia G Said; Roger W Beuerman; Rajamani Lakshminarayanan; Imran Mohammed; Harminder S Dua
Journal:  Front Pharmacol       Date:  2021-10-07       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.